ChemoCentryx, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
71.63
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-06-30
|
-0.49
|
-0.44
|
0.05
|
10.20%
|
|
2022-03-31
|
-0.31
|
-0.55
|
-0.24
|
-77.42%
|
|
2021-12-31
|
-0.58
|
-0.58
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.45
|
-0.32
|
0.13
|
28.89%
|
|
2021-06-30
|
-0.55
|
-0.56
|
-0.01
|
-1.82%
|
|
2021-03-31
|
-0.40
|
-0.43
|
-0.03
|
-7.50%
|
|
2020-12-31
|
-0.33
|
-0.43
|
-0.10
|
-30.30%
|
|
2020-09-30
|
-0.31
|
-0.35
|
-0.04
|
-12.90%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.99
|
|
2021-12-31
|
-1.89
|
|
2020-12-31
|
-0.84
|
|
2019-12-31
|
-0.97
|
|
2018-12-31
|
-0.76
|
|
2017-12-31
|
0.36
|
|
2016-12-31
|
-0.87
|
|
2015-12-31
|
-1.08
|
|
2014-12-31
|
-1.08
|
|
2013-12-31
|
-0.95
|
|
2012-12-31
|
-1.14
|
|
2011-12-31
|
4.33
|